Global Point of Care
BACK
Home > Products

ID NOW™ Influenza A & B 2

There is no time like ID NOW.

Formerly Alere™ i. The Fastest Rapid Molecular Flu Test. Plus a new name.

The ID NOW™ Influenza A & B 2 assay delivers molecular flu results in 13 minutes or less on our unique ID NOW™ platform; making it significantly faster than other molecular methods and more accurate than conventional rapid tests. Rapid diagnostic tests with increased sensitivity are essential for the reliable detection of influenza A and B and enable immediate, effective treatment decisions.1

Benefits
  • Early detection – positive results in as few as 5 minutes, with 95% detected within 7 minutes2
  • Negative results in 13 minutes
  • Detects up to 42% more true positives than RADTs3
  • Room temperature storage
  • CLIA waived
  • Preferred sample type4
  • Gives you the confidence to make clinical decisions sooner
  • Facilitates effective patient management
  • Aids targeted antiviral therapy and Antimicrobial Stewardship
Helpful Documents
  • Highly accurate results in 13 minutes
  • Specimen types: Nasal Swab Direct or in Viral Transport Media (VTM), Nasopharyngeal Swab Direct or in VTM
  • Small footprint enables ease of use at the point of care
  • Simple operation via visual touchscreen

ID NOW™ Influenza A & B 2 vs. PCR3

Direct Swab Sensitivity Specificity
Flu A 96.3% 97.4%
Flu B 100% 97.1%
VTM Sensitivity Specificity
Flu A 92.8% 98.5%
Flu B 100% 97.7%
ID NOW™ System
 Code
ID NOW™ Instrument
 NAT-024 (US)
ID NOW™ Influenza A & B 2  24 Test Kit 427-000 (Global)
ID NOW™ Influenza A & B Control Swab Kit 425-080 (Global & US)
ID NOW™ Barcode Scanner OPR2001ZWU1201 (Global & US)
Universal Printer 55115 (Global)
  IDNOWPRINT, formerly alereiprinter (US)
Related Products
ID NOW™ COVID-19
ID NOW™ COVID-19
ID NOW™
ID NOW™
ID NOW™ RSV
ID NOW™ RSV
Alere™ i Strep A 2
ID NOW™ STREP A 2
  1. Williams, KM, Jackson MA, Hamilton M. Rapid Diagnostic Testing for URIs in Children: Impact on Physician Decision Making and Cost. Infect. Med. 19(3): 109‐ 111, 2002.
  2. Moore N, et al. Evaluation of the Alere™ i Influenza A & B 2 Assay. 2018 ASM Clinical Virology Symposium, West Palm Beach, FL. Poster.
  3. Chartrand et al, Accuracy of Rapid Influenza Diagnostic Tests A Meta-analysis; Ann-Intern Med. 2012; 156;500-5114.
  4. Ipp, M., Carson S., Petric, M., Parkin P C. Rapid painless diagnosis of viral respiratory infection. Arch Dis Child. 86: 372–373, 2002. 2
  5. Alere™ i Influenza A & B 2 Package Insert.

Stay informed

Sign up to receive valuable updates from Abbott.

Need Technical Support?

Click here to get in touch with our technical support team.

   

False
accessibility

   

YesNo
accessibility

   

YesNo
accessibility

   

YesNo
accessibility

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. Not all products are available in all regions. Check with your local representative for availability in specific markets. For In Vitro Diagnostic Use Only. For the use of registered medical practitioners, hospitals and Laboratories only.

I understand